% | $
Quotes you view appear here for quick access.

AmpliPhi Biosciences Corporation Message Board

  • leytonorientfan leytonorientfan Jul 12, 2013 5:55 AM Flag

    New Edison research just out

    There's a new catch-up note out from Edison - with a first full note to follow:


    "Investment summary: Turning a fresh p(h)age

    A $7m private placement with RA Capital and Third Security, and a research collaboration with the US army, provide AmpliPhi with fresh impetus in its development of bacteriophages. These deals build on the purchase of Special Phage Services (SPS) last year and a recent strategic collaboration with Intrexon. AmpliPhi is the only company to have completed a controlled Phase I/II study with bacteriophages (naturally-occurring viruses that kill bacteria). The next steps towards technology validation are Phase I and II studies with the US army in 2014 in skin infections due to S Aureus, and a Phase II study to treat Pseudomonas infections in cystic fibrosis (CF)."

    "Valuation: Modest $25m EV

    We estimate AmpliPhi’s EV at $25m, based on 197m total shares now outstanding and $6.85m net cash at end-Q213. We view this as modest, particularly with regard to the CF opportunity. We will initiate full coverage of AmpliPhi in due course."

    Sentiment: Strong Buy

    SortNewest  |  Oldest  |  Most Replied Expand all replies
8.500.00(0.00%)Aug 20 3:48 PMEDT